A study by Sonnylal et al. showed that constitutive activation of TGF-β1 signaling in fibroblasts in mice developed histopathological features of dermal fibrosis as recognized in patients with SSc [52]. This evidence concerns the gene TGFB1 and systemic sclerosis.